866 filings
424B5
DRRX
Durect Corp
28 Mar 24
Prospectus supplement for primary offering
5:26pm
10-K
2023 FY
DRRX
Durect Corp
Annual report
28 Mar 24
4:52pm
8-K
DRRX
Durect Corp
27 Mar 24
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
SC 13G
DRRX
Durect Corp
27 Mar 24
DURECT / INGALLS & SNYDER ownership change
3:15pm
8-K
DRRX
Durect Corp
22 Mar 24
Other Events
4:05pm
8-K
s85 fiwn9ev
4 Mar 24
DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZETĀ® Product Line in U.S. and Canada
11:37am
SC 13G
p5u 2qeqae5ttla
16 Feb 24
DURECT / ASEN R SCOTT ownership change
4:09pm
SC 13G/A
2eejfgh
14 Feb 24
DURECT / Lion Point Capital ownership change
4:16pm
8-K
87exqz70kqd4c
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
SC 13G/A
ni121
1 Dec 23
DURECT / Bleichroeder ownership change
4:28pm
8-K
fve1kzlhjtjk 930
13 Nov 23
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
4:15pm
8-K
c3fwn0i52bl57efusbv
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
i1z 8xvz8i7xejllw
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
S-8
t8tyge7
10 Aug 23
Registration of securities for employees
4:21pm
8-K
bvi9fwb1
9 Aug 23
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
4:23pm
8-K
o2cc03k t8
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
424B5
8zh2gro3h3
21 Jul 23
Prospectus supplement for primary offering
10:38am
4
5zauavp
23 Jun 23
DURECT / Judith J. Robertson ownership change
5:33pm